+

WO2001049712A3 - Vaccine against isav (infectious salmon anaemia virus) - Google Patents

Vaccine against isav (infectious salmon anaemia virus) Download PDF

Info

Publication number
WO2001049712A3
WO2001049712A3 PCT/EP2001/000046 EP0100046W WO0149712A3 WO 2001049712 A3 WO2001049712 A3 WO 2001049712A3 EP 0100046 W EP0100046 W EP 0100046W WO 0149712 A3 WO0149712 A3 WO 0149712A3
Authority
WO
WIPO (PCT)
Prior art keywords
infectious salmon
salmon anaemia
vaccine against
anaemia virus
isav
Prior art date
Application number
PCT/EP2001/000046
Other languages
French (fr)
Other versions
WO2001049712A2 (en
Inventor
Eirik Biering
Bjoern Krossoey
Original Assignee
Akzo Nobel Nv
Eirik Biering
Bjoern Krossoey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Eirik Biering, Bjoern Krossoey filed Critical Akzo Nobel Nv
Priority to AU35394/01A priority Critical patent/AU3539401A/en
Publication of WO2001049712A2 publication Critical patent/WO2001049712A2/en
Publication of WO2001049712A3 publication Critical patent/WO2001049712A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention concerns a vaccine for treatment and/or prevention of infectious salmon anaemia in fish. The invention provides for nucleic acid sequence encoding viral proteins of Infectious Salmon Anaemia Virus (ISAV) as well as the isolated (recombinant) protein, which can be used to prepare the vaccine. The invention furthermore pertains to antibodies that are reactive with said viral proteins and their use in diagnostics.
PCT/EP2001/000046 2000-01-07 2001-01-03 Vaccine against isav (infectious salmon anaemia virus) WO2001049712A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU35394/01A AU3539401A (en) 2000-01-07 2001-01-03 Vaccine for prevention and/or prophylaxis of infectious salmon anaemia in fish

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00200054 2000-01-07
EP00200054.5 2000-01-07
EP00200700 2000-02-29
EP00200700.3 2000-02-29

Publications (2)

Publication Number Publication Date
WO2001049712A2 WO2001049712A2 (en) 2001-07-12
WO2001049712A3 true WO2001049712A3 (en) 2002-04-18

Family

ID=26071717

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/000046 WO2001049712A2 (en) 2000-01-07 2001-01-03 Vaccine against isav (infectious salmon anaemia virus)

Country Status (2)

Country Link
AU (1) AU3539401A (en)
WO (1) WO2001049712A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1200132E (en) 1999-08-07 2006-11-30 Novartis Ag Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
AU2001295584A1 (en) * 2000-09-28 2002-04-08 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus
WO2005035558A2 (en) 2003-10-07 2005-04-21 Michel Thiry Piscirickettsia salmonis antigens and use thereof
NZ578541A (en) 2006-12-22 2012-04-27 Soluciones Biotecnologicas Innovacion Ltda Dna vaccines for fish
US7811583B2 (en) 2007-12-19 2010-10-12 Intervet International B.V. Antigens and vaccines against Piscirickettsia salmonis
WO2020132770A1 (en) * 2018-12-28 2020-07-02 Universidad De Santiago De Chile Virus-like particles (vlp) of the infectious salmon anemia virus (isav) that comprise matrix protein and one or more antigenic proteins of the virus; production method, composition, vaccine and fish feed; recombinant baculovirus; and vaccination kit; and

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839913A2 (en) * 1996-11-04 1998-05-06 Ottawa Civic Hospital DNA-Based vaccination of fish by immersion

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839913A2 (en) * 1996-11-04 1998-05-06 Ottawa Civic Hospital DNA-Based vaccination of fish by immersion

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL/GENBANK/DDBJ EBI; 1 October 2000 (2000-10-01), "Hypothetical 42.8 kDa protein", XP002171032 *
FALK K ET AL: "CHARACTERIZATION AND APPLICATIONS OF A MONOCLONAL ANTIBODY AGAINST INFECTIOUS SALMON ANAEMIA VIRUS", DISEASES OF AQUATIC ORGANISMS, vol. 34, no. 2, 8 October 1998 (1998-10-08), pages 77 - 85, XP000892505 *
FALK, K. ET AL.: "Characterization of Infectious Salmon Anemia Virus, an Orthomyxo-Like Virus Isolated from Atlantic Salmon (salmo salar L.).", J. VIROL., vol. 71, no. 12, December 1997 (1997-12-01), pages 9016 - 9023, XP002139684 *
JONES S R M ET AL: "VACCINATION OF FRESHWATER-REARED ATLANTIC SALMON REDUCES MORTALITY ASSOCIATED WITH INFECTIOUS SALMON ANAEMIA VIRUS", BULLETIN OF THE EUROPEAN ASSOCIATION OF FISH PATHOLOGY, vol. 19, no. 3, July 1999 (1999-07-01), pages 98 - 101, XP000890013 *
MJAALAND, S. ET AL.: "Genomic Characterization of the Virus Causing Infectious Salmon Anemia in Atlantic Salmon (Salmo salar L.): an Orthomyxo-Like Virus in a Teleost.", J. VIROL., vol. 71, no. 10, October 1997 (1997-10-01), pages 7681 - 7686, XP002139683 *

Also Published As

Publication number Publication date
AU3539401A (en) 2001-07-16
WO2001049712A2 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
WO2002053703A3 (en) Aav2 vectors and methods
AU2774389A (en) Recombinant vaccinia virus mva
WO2001098333A3 (en) Modification of hepatitis b core antigen
WO2003040187A1 (en) Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
WO2002022664A3 (en) Antigenic proteins of shrimp white spot syndrome virus and uses thereof
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
MXPA05005202A (en) Vaccine.
WO2005035558A3 (en) Piscirickettsia salmonis antigens and use thereof
EP1613345A4 (en) Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
WO2002027007A3 (en) Production of viral vectors
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
MXPA02012593A (en) Bvdv virus-like particles.
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
WO2005011571A3 (en) Hepatitis virus core proteins as vaccine platforms and methods of use thereof
WO2009051823A3 (en) Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof
WO2000066743A3 (en) Viral expression vectors
NO20005217D0 (en) DNA encoding structural protein-1 in infectious salmon anemia virus and its use
WO1998042847A3 (en) Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
WO1998023752A3 (en) Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
WO2004032622A8 (en) Production of peptides in plants as viral coat protein fusions
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
WO1997040166A3 (en) Simian-human hav having a chimeric 2c protein
WO2002002142B1 (en) Papillomavirus vaccine
WO2005001096A8 (en) Vaccines against sars

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP NO NZ US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP NO NZ US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWE Wipo information: entry into national phase

Ref document number: 165888

Country of ref document: IL

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载